NYSE:CANF | Free Cash Flow | Can-Fite BioPharma Ltd.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$8.95M$2,000.00-$8.95M
2024-12-31-$7.64M$5,000.00-$7.64M
2023-12-31-$8.44M$2,000.00-$8.44M
2022-12-31-$10.8M$9,000.00-$10.81M
2021-12-31-$9.86M$11,000.00-$9.87M
2020-12-31-$12.06M$26,000.00-$12.09M
2019-12-31-$11.08M$3,000.00-$11.09M
2018-12-31-$4.16M$33,000.00-$4.19M